Table 5.
N | Mean (95% CI)* P value | Heterogeneity P value | |
---|---|---|---|
Change in pain (VAS 0–10 mm) | 14 | MD −5.4 mm (95% CI −6.3 to −4.4)* P < 0.0001 | <0.0001 |
Change in functional capacity (different scales) | 5 | SMD 1.0 (0.6 to 1.5)* <0.0001 | <0.0001 |
Change in quality of life (SF-36 0–100) | |||
Physical functioning | 5 | MD −21 (−28 to −14)* <0.0001 | 0.036 |
Role physical | 4 | MD −31 (−42 to −20)* <0.0001 | 0.009 |
Bodily pain | 5 | MD −29 (−38 to −19)* <0.0001 | <0.0001 |
General health | 5 | MD +4 (−2 to 10)* 0.266 | 0.013 |
Vitality | 5 | MD −11 (−14 to −8) <0.0001 | 0.146 |
Social functioning | 5 | MD −29 (−39 to −18)* <0.0001 | 0.001 |
Role emotional | 4 | MD −18 (−39 to 4)* 0.109 | <0.0001 |
Mental health | 5 | MD −11 (−17 to −5)* <0.0001 | 0.008 |
Satisfaction at follow up (%) | 2 | MD 98 (90 to 100) <0.001 | 0.973 |
Change in vertebral height (% original height) | 9 | MD 21 (15 to 26)* <0.0001 | <0.0001 |
Change in kyphotic angle (°) | 12 | MD −6.3 (−5.8 to −6.7) <0.0001 | 0.826 |
* Random effects model
MD mean difference, SMD standardised mean difference